Scientific Research

The secret for best clinical practice

Hockey: kniespecialist RPA Janssen Voorste kruisband op maat. Kniespecialist RPA Janssen
Read more →

e/MTIC symposium TU/e

RPA Janssen MD PhD visits the Symposium Technology meets Value-Based Health Care. This...

Read more →

Two new publications

RPA Janssen MD PhD is co-author of 2 new peer reviewed publications this month in Knee...

Read more →

Keynote lecture KNGF: Up to date treatment ACL injury

Nicky van Melick PT PhD and Rob...

Follow me!

Remain up to date with all the latest knee facts via Facebook, Twitter and other social networks

Culturing human osteoarthritic osteochondral explants

Culturing human osteoarthritic osteochondral explants

Meike W.A. Kleuskens, (René) C.C. van Donkelaar, Rob P.A. Janssen and Keita Ito

Current knee osteoarthritis (OA) treatments are sub-optimal and not long-lasting. Within the osteoarthritis moonshot, osteochondral implants for focal cartilage defects are developed which need to regenerate cartilage and bone and integrate with the adjacent tissues. The challenge is to explore and optimize this in an in vitrosetting, to identify the most promising implants for the ultimate animal studies. This may be done by inserting the implant in an osteochondral defect that is created in an osteochondral explant in culture. To do so, it is necessary to first demonstrate that an osteochondral explant can be kept in culture for a longer time while preserving its properties and composition. Aim of the present study is therefore to characterize human osteochondral tissue at various stages of OA, and to develop an approach to culture OA tissue for 28 days. 

Osteochondral explants (Ø10mm) with either a smooth or fibrillated cartilage surface, representing different OA stages, were harvested from human tibia plateaus obtained from total knee replacement surgeries at the Maxima Medical Centre, Eindhoven and were cultured in a double-chamber culture platform (figure 1).[1]Fresh and cultured explants were evaluated for their viability, biochemical tissue content and cellular gene expression. Moreover, sections were stained with safranin-O/fast green for analysis of the proteoglycan and collagen distribution and to determine the grade of OA using the Mankin scoring system.[2]

Statistical differences between smooth and fibrillated cartilage were found in biochemical and histological analyses of fresh cartilage (average Mankin score of 3.4 vs. 5.1, proteoglycan content of 8.4 ± 1.7%dwvs. 13.5 ± 3.2%dw, collagen content of 39.9 ± 3.8%dwvs. 29.3 ± 4.6%dwrespectively). Preliminary results of the cultures reveal that chondrocyte viability was maintained over 28 days, but bone tissue was less viable. Analysis of the cultured samples is ongoing to explore whether the biochemical and histological composition of the cartilage is preserved over time. 


[1]Andrea Schwab and others, ‘Ex Vivo Culture Platform for Assessment of Cartilage Repair Treatment Strategies’, Altex, 34.2 (2017), 267–77 <https://doi.org/10.14573/altex.1607111>.

[2]H J Mankin and others, ‘Biochemical and Metabolic Abnormalities in Articular Cartilage from Osteo-Arthritic Human Hips. II. Correlation of Morphology with Biochemical and Metabolic Data.’, The Journal of Bone and Joint Surgery. American Volume, 53.3 (1971), 523–37.

← Back to publications


RPA Janssen, MD PhD 
Orthopaedic Surgeon
Orthopaedic Associates Eindhoven Greater Area
Orthopedic Center Máxima
Máxima Medical Center (MMC)

Visiting adress MMC Eindhoven:
Ds. Th. Fliednerstraat 1
Ingang Zuid
5631 BM  Eindhoven
The Netherlands 
(outpatient clinic and surgery)

Visiting adress MMC Veldhoven:
De Run 4600
5504 DB  Veldhoven
The Netherlands
(Outpatient clinic)

Mail adress:
Postbus 90052
5600 PD  Eindhoven
The Netherlands

Tel. 0031 (0)40 88 88 600
(Call center Orthopedie)

Fax: 0031 (0)40 88 85 938

Orthopaedic Associates Eindhoven Greater Area
Máxima Medical Center
Orthopaedic Center Máxima

RPA Janssen YouTube
RPA Janssen Twitter
RPA Janssen Facebook
RPA Janssen LinkedIn
RPA Janssen weblog